Antifungal liposomes: Lipid saturation and cholesterol concentration impact interaction with fungal and mammalian cells
Journal of Biomedical Materials Research Part A · 2023
DOI: 10.1002/jbm.a.37501 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, 2023. Verfasst von Veronica LaMastro und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Engineering, Center for Biomedical Engineering, Brown University, Providence, Rhode Island, USA. Hauptthemen laut MEDLINE: Liposomes, Antifungal Agents. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Brown University, NIGMS NIH HHS, National Science Foundation.
Abstract (Originalsprache)
Liposomes are lipid‐based nanoparticles that have been used to deliver encapsulated drugs for a variety of applications, including treatment of life‐threatening fungal infections. By understanding the effect of composition on liposome interactions with both fungal and mammalian cells, new effective antifungal liposomes can be developed. In this study, we investigated the impact of lipid saturation and cholesterol content on fungal and mammalian cell interactions with liposomes. We used three phospholipids with different saturation levels (saturated hydrogenated soy phosphatidylcholine (HSPC), mono‐unsaturated 1‐palmitoyl‐2‐oleoyl‐glycero‐3‐phosphocholine (POPC), and di‐unsaturated 1‐palmitoyl‐2‐linoleoyl‐sn‐glycero‐3‐phosphocholine (PLPC)) and cholesterol concentrations ranging from 15% to 40% (w/w) in our liposome formulations. Using flow cytometry, >80% of Candida albicans SC5314 cells were found to interact with all liposome formulations developed, while >50% of clinical isolates tested exhibited interaction with these liposomes. In contrast, POPC‐containing formulations exhibited low levels of interaction with murine fibroblasts and human umbilical vein endothelial cells (50% and >80% interaction, respectively. Further, PLPC formulations caused a significant decrease in mammalian cell viability. Formulations that resulted in low levels of mammalian cell interaction, minimal cytotoxicity, and high levels of fungal cell interaction were then used to encapsulate the antifungal drug, amphotericin B. These liposomes eradicated planktonic C. albicans at drug concentrations lower than free drug, potentially due to the high levels of liposome‐ C. albicans interaction. Overall, this study provides new insights into the design of liposome formulations towards the development of new antifungal therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Engineering, Center for Biomedical Engineering, Brown University, Providence, Rhode Island, USA.
- Department of Chemistry, Brown University, Providence, Rhode Island, USA.
ORCID-Profile: Anita Shukla
Förderung
- Brown University
- NIGMS NIH HHS
- National Science Foundation
- National Institutes of Health
Zitieren
APA
LaMastro, V., Campbell, K. M., Gonzalez, P., Meng-Saccoccio, T., & Shukla, A. (2023). Antifungal liposomes: Lipid saturation and cholesterol concentration impact interaction with fungal and mammalian cells. Journal of Biomedical Materials Research Part A. https://doi.org/10.1002/jbm.a.37501
Vancouver
LaMastro V, Campbell KM, Gonzalez P, Meng-Saccoccio T, Shukla A. Antifungal liposomes: Lipid saturation and cholesterol concentration impact interaction with fungal and mammalian cells. Journal of Biomedical Materials Research Part A. 2023. doi:10.1002/jbm.a.37501
BibTeX
@article{LaMastro2023,
author = {LaMastro, Veronica and Campbell, Kayla M and Gonzalez, Peter and Meng-Saccoccio, Tobias and Shukla, Anita},
title = {Antifungal liposomes: Lipid saturation and cholesterol concentration impact interaction with fungal and mammalian cells},
journal = {Journal of Biomedical Materials Research Part A},
year = {2023},
doi = {10.1002/jbm.a.37501}
}
EUVIMED